New Jersey Senate Bill S1186

New Jersey 2022-2023 Regular Session

• Introduced: 1/31/22
• Refer: 1/31/22

Caption

Requires health insurers to disclose broker commissions to purchasers.

Impact

The bill amends existing regulations related to health insurance sales by reinforcing the obligation of insurers to provide clear information regarding broker commissions. This adjustment could potentially lead to a more competitive market where consumers can compare health benefits more effectively, possibly resulting in better pricing and offerings from insurers. Additionally, it aims to foster trust between insurers and consumers as transparency is enhanced.

Summary

Senate Bill S1186, introduced in the New Jersey State Legislature, requires health insurers to disclose the commissions they pay to brokers at the time of sale of health benefits plans. This legislation shifts the responsibility of disclosing commission information from the brokers (insurance producers) to the insurers themselves, ensuring that consumers are informed of the compensation structure involved in their insurance products at the moment of purchase. Such transparency is intended to empower consumers to make more informed decisions regarding their health insurance options.

Contention

While the bill is aimed at increasing transparency, it may face opposition from brokers who might argue that the new requirements could complicate the sales process or dissuade potential clients due to concerns about commissions. There could be concerns about how this change might affect the relationship between brokers and insurers, particularly if brokers feel that the requirement undermines their role in the sales process. Furthermore, the bill grants the Department of Banking and Insurance the authority to regulate additional disclosure requirements, which may lead to ongoing discussions about regulations and their implications for the industry.